Efficacy analysis of the aprepitant-combined antiemetic prophylaxis for non-round cell soft-tissue sarcoma patients received adriamycin and ifosfamide therapy.

In terms of the delayed phase, triplet therapy only showed a trend of favorable CR rate (75% vs 50%; P = 0.102), possibly because of the limited number of patients and alteration of the plasma concentration of DEX caused by 5-day schedule of antiemetic therapy.

also in 53,322 other papers